Brooklyn Investment Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
23,110
+4,777
+26% +$223K 0.04% 483
2025
Q4
$571K Buy
+18,333
New +$498K 0.03% 587
2025
Q3
– Sell
-4,316
Closed -$119K – 1927
2025
Q2
$119K Buy
4,316
+2,281
+112% +$60.1K 0.02% 855
2025
Q1
$57.7K Buy
2,035
+1,257
+162% +$44.6K 0.01% 725
2024
Q4
$32.4K Sell
778
-416
-35% -$19.9K 0.01% 641
2024
Q3
$79.8K Buy
+1,194
New +$110K 0.03% 388

Other funds holding MRNA

Brooklyn Investment Group's MRNA Position: Q1 2026 in Review

Brooklyn Investment Group increased its Moderna (MRNA) stake by 26% in Q1 2026, buying an estimated $223K and bringing the position to 23,110 shares worth $1.17M. The position accounts for 0.04% of the portfolio, ranked #483.

Brooklyn Investment Group first reported a position in MRNA in Q3 2024 and has held it in 6 quarters since. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Brooklyn Investment Group held 23,110 shares of Moderna worth $1.17M as of Q1 2026.
  • Brooklyn Investment Group bought 4,777 Moderna shares in Q1 2026, an estimated $223K.
  • Moderna made up 0.04% of Brooklyn Investment Group's portfolio in Q1 2026, its #483 holding.
  • Brooklyn Investment Group first reported a position in Moderna in Q3 2024 and has held it in 6 quarters since.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.